Purchase Order 75D30124P19812
Award Date
8/28/24
Potential Completion Date
11/27/24
Potential Value
$220K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
334513 - Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $205,000 purchase order to Qiagen, LLC for their EZ! ADVANCED XL SYSTEM. Qiagen, a subsidiary of Qiagen N.V., will provide its sample preparation and nucleic acid extraction platform to support CDC programs through a one-month period of performance ending in late August 2023. The firm fixed price contract calls for Qiagen to deliver its proprietary system to help CDC process samples...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $79,796.08 firm-fixed-price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the purchase of a QIAGEN EZ2 Connect MDX system. This equipment will support the CDC's biomedical research, public health, and healthcare programs. Qiagen has provided a range of laboratory products and services to various federal agencies in the past, including the Department of Health...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $82,823.10 firm fixed price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the EZ2 CONNECT MDX SYSTEM FUL-3. This system supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. The contract has no set-aside designation and is scheduled for completion by...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $64,817.75 contract provides planned maintenance services for QIAGEN equipment, with a period of performance through March 31, 2024. Qiagen is a major supplier of molecular diagnostics products and services to federal agencies, including the Department of Health and Human Services, Department of Veterans...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Qiagen, LLC for a PYROMARK Q48 SYSTEM with a completion date of July 20, 2019 and a potential value of $139,884.28. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies. Qiagen has provided a range of products and services, including DNA/RNA extraction kits, next-generation sequencing, and precision medicine...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $133,979.07 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of laboratory equipment and furniture, with a completion date of November 15, 2023. Qiagen is a manufacturer of products and provider of services to support federal agencies' biomedical research, public health, law enforcement, and...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $32,000 purchase order to Qiagen, LLC for a QIAGEN ROBOT. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor to deliver the robotic system to the CDC location in Germantown, Maryland between September 12-29, 2023. The contract has a firm fixed price and will support the CDC's efforts to modernize its laboratory equipment and processes. No major...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a subsidiary of the Qiagen N.V. biotechnology company. The $113,138.05 contract is for the provision of QIACUBE HT/QIAXTRACTOR platform equipment, which supports the CDC's biomedical research, public health, and healthcare programs. Qiagen is a well-established federal contractor, holding multiple indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with...